Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients
Autore:
Madyoon, H; Croushore, L; Weaver, D; Mathur, V;
Indirizzi:
St Josephs Med Ctr, Stockton, CA 95204 USA St Josephs Med Ctr Stockton CAUSA 95204 Med Ctr, Stockton, CA 95204 USA Henry Ford Hosp, Detroit, MI 48202 USA Henry Ford Hosp Detroit MI USA 48202 nry Ford Hosp, Detroit, MI 48202 USA Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco San Francisco CA USA 94143 ancisco, CA 94143 USA
Titolo Testata:
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
fascicolo: 3, volume: 53, anno: 2001,
pagine: 341 - 345
SICI:
1522-1946(200107)53:3<341:UOFTPR>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACUTE-RENAL-FAILURE; CONTRAST-MEDIA; CORONARY ANGIOPLASTY; BLOOD-FLOW; NEPHROTOXICITY; DOPAMINE; NITROPRUSSIDE; HEMODYNAMICS; KIDNEY;
Keywords:
dopamine agonist; acute renal failure; contrast; kidney; angiography;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
28
Recensione:
Indirizzi per estratti:
Indirizzo: Madyoon, H St Josephs Med Ctr, 1800 N Calif St, Stockton, CA 95204 USA St Josephs Med Ctr 1800 N Calif St Stockton CA USA 95204 04 USA
Citazione:
H. Madyoon et al., "Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients", CATHET C IN, 53(3), 2001, pp. 341-345

Abstract

We evaluated the ability of fenoldopam, a newly available renal vasodilator, to prevent radiocontrast nephropathy in high-risk patients undergoing interventional diagnostic and therapeutic angiographic procedures. We reviewed the results from 46 consecutive procedures in patients with serum creatinine, 1.5 mg/dL if diabetic and > 1.7 mg/dL if nondiabetic. We compared our results to a previously published cohort of similarly at-risk patients. Theincidence of radiocontrast nephropathy, defined as an increase in serum creatinine of greater than or equal to 25% at 48 hr following the procedure, was 13% in the group treated with fenoldopam, compared to an expected 38%, The percentage change in serum creatinine at 48 hr was +16% vs. +118%, respectively, in the two groups. In this preliminary experience, the use of fenoldopam in high-risk patients appears to minimize the likelihood of radioncontrast nephropathy. (C) 2001 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/20 alle ore 01:59:54